Original Research
Published on 03 Oct 2024
Efficacy and safety of anlotinib for triple-negative breast cancer with brain metastases
in Breast Cancer
Original Research
Published on 03 Oct 2024
in Breast Cancer
Original Research
Accepted on 02 Oct 2024
in Inflammation
Original Research
Accepted on 02 Oct 2024
in Inflammation
Mini Review
Accepted on 02 Oct 2024
in Cognition
Original Research
Accepted on 02 Oct 2024
in Microbial Immunology
Original Research
Accepted on 02 Oct 2024
in Public Health Education and Promotion
Original Research
Accepted on 02 Oct 2024
in Pathology
Original Research
Accepted on 02 Oct 2024
in Public Mental Health
Original Research
Accepted on 02 Oct 2024
in Neuro-Otology
Original Research
Accepted on 02 Oct 2024
in Neuroimaging Analysis and Protocols
Original Research
Accepted on 02 Oct 2024
in Cell and Gene Therapy
Original Research
Accepted on 02 Oct 2024
in Headache and Neurogenic Pain
Original Research
Accepted on 02 Oct 2024
in Ethnopharmacology
Original Research
Accepted on 02 Oct 2024
in Microbes and Innate Immunity
Review
Accepted on 02 Oct 2024
in Anti-Infective Agents
Original Research
Accepted on 02 Oct 2024
in Educational Psychology